These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
    Author: Aparicio AM, Elkhouiery AB, Quinn DI.
    Journal: Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619.
    Abstract:
    Urothelial transitional cell cancer has a high rate of response to combination cytotoxic therapy. Approximately 50% of patients with high-grade bladder cancer and deep muscle invasion ultimately die of disseminated disease. Translating the high response seen in locally advanced disease into long-term survival in the metastatic setting and to improved survival in the advanced setting has proved difficult. This article reviews the use of adjuvant chemotherapy in localized or locally advanced transitional cell cancer. The chemotherapy of urological malignancies, including bladder cancer, has recently been reviewed in detail; this article does not contain an extensive review of the drugs used.
    [Abstract] [Full Text] [Related] [New Search]